Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax Provisions
Others
Ratios

Arcus Biosciences (RCUS) EPS (Basic): 2017-2024

Historic EPS (Basic) for Arcus Biosciences (RCUS) over the last 8 years, with Dec 2024 value amounting to -$3.14.

  • Arcus Biosciences' EPS (Basic) fell 27.00% to -$1.27 in Q3 2025 from the same period last year, while for Sep 2025 it was -$4.44, marking a year-over-year decrease of 40.95%. This contributed to the annual value of -$3.14 for FY2024, which is 24.34% up from last year.
  • Per Arcus Biosciences' latest filing, its EPS (Basic) stood at -$3.14 for FY2024, which was up 24.34% from -$4.15 recorded in FY2023.
  • Over the past 5 years, Arcus Biosciences' EPS (Basic) peaked at $0.76 during FY2021, and registered a low of -$4.15 during FY2023.
  • Moreover, its 3-year median value for EPS (Basic) was -$3.71 (2022), whereas its average is -$3.67.
  • Per our database at Business Quant, Arcus Biosciences' EPS (Basic) surged by 133.93% in 2021 and then slumped by 588.16% in 2022.
  • Arcus Biosciences' EPS (Basic) (Yearly) stood at -$2.24 in 2020, then skyrocketed by 133.93% to $0.76 in 2021, then crashed by 588.16% to -$3.71 in 2022, then declined by 11.86% to -$4.15 in 2023, then rose by 24.34% to -$3.14 in 2024.